Senator Dave McCormick Discusses AI in Hospital Supply Chains and Drug Reshoring

Enhancing Transparency in Medicine Origins

• 💊 Current transparency for patients regarding the origin country of medicines and their APIs is virtually non-existent.
• 🏷️ Improvements could be made through labeling, indicating critical steps like aseptic filling in sterile environments, to allow market forces to address supply chain issues.

Leveraging AI for Supply Chain Mapping

• 🤖 Artificial intelligence can be deployed to break down the bill of materials for pharmaceuticals and identify literal suppliers.
• 🗺️ It's crucial to map not only the products being purchased but also the spectrum of alternative suppliers available before disruptions occur.
• ⚠️ This visibility can enable proactive measures like stockpiling and prevent life-threatening shortages, particularly in critical areas like operating rooms.

Advancing Reshoring and Nearshoring of Pharmaceuticals

• 🏭 Key challenges to reshoring include permitting backlogs and delays for new facilities.
• 🧪 Manufacturing certain drugs, like acetaminophen, generates waste that is restricted by EPA regulations in the US, unlike in India or China.
• 🔬 Novel manufacturing methods and advanced research and development, such as continuous flow manufacturing, are being explored to overcome these hurdles.
• ⚙️ Implementing AI and automation in the manufacturing process can reduce labor costs and make US-based pharmaceutical manufacturing competitive globally.